Australia markets closed

Universe Pharmaceuticals INC (UPC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.2600-0.1100 (-4.64%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
32,309
32,309
40,143
47,982
30,704
Cost of revenue
21,994
21,994
18,252
22,656
16,610
Gross profit
10,315
10,315
21,891
25,326
14,094
Operating expenses
Research development
4,859
4,859
7,644
5,466
583.125
Selling general and administrative
9,001
9,001
20,836
6,043
2,795
Total operating expenses
14,281
14,281
28,911
11,966
3,744
Operating income or loss
-3,966
-3,966
-7,019
13,360
10,350
Interest expense
156.788
156.788
162.4
101.604
123.76
Total other income/expenses net
273.315
273.315
-802.302
420.117
-125.633
Income before tax
-3,850
-3,850
-7,984
13,678
10,100
Income tax expense
2,313
2,313
752.419
2,359
2,542
Income from continuing operations
-6,163
-6,163
-8,737
11,320
7,558
Net income
-6,163
-6,163
-8,737
11,320
7,558
Net income available to common shareholders
-6,163
-6,163
-8,737
11,320
7,558
Basic EPS
-3.08
-
-2.41
3.58
2.16
Diluted EPS
-3.08
-
-2.41
3.58
2.16
Basic average shares
3,625
-
3,625
3,163
3,500
Diluted average shares
3,625
-
3,625
3,163
3,500